Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Author's Takes
  • Reviews
    • View all reviews ...
    • Immune Environment in Glioblastoma (Feb 2023)
    • Korsmeyer Award 25th Anniversary Collection (Jan 2023)
    • Aging (Jul 2022)
    • Next-Generation Sequencing in Medicine (Jun 2022)
    • New Therapeutic Targets in Cardiovascular Diseases (Mar 2022)
    • Immunometabolism (Jan 2022)
    • Circadian Rhythm (Oct 2021)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Commentaries
    • Research letters
    • Letters to the editor
    • Editorials
    • Viewpoint
    • Top read articles
  • Clinical Medicine
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Author's Takes
  • In-Press Preview
  • Commentaries
  • Research letters
  • Letters to the editor
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact
Foxo1 is required in mouse spermatogonial stem cells for their maintenance and the initiation of spermatogenesis
Meredith J. Goertz, … , F. Kent Hamra, Diego H. Castrillon
Meredith J. Goertz, … , F. Kent Hamra, Diego H. Castrillon
Published August 25, 2011
Citation Information: J Clin Invest. 2011;121(9):3456-3466. https://doi.org/10.1172/JCI57984.
View: Text | PDF
Research Article Reproductive biology

Foxo1 is required in mouse spermatogonial stem cells for their maintenance and the initiation of spermatogenesis

  • Text
  • PDF
Abstract

Spermatogonial stem cells (SSCs) capable of self-renewal and differentiation are the foundation for spermatogenesis. Although several factors important for these processes have been identified, the fundamental mechanisms regulating SSC self-renewal and differentiation remain unknown. Here, we investigated a role for the Foxo transcription factors in mouse spermatogenesis and found that Foxo1 specifically marks mouse gonocytes and a subset of spermatogonia with stem cell potential. Genetic analyses showed that Foxo1 was required for both SSC homeostasis and the initiation of spermatogenesis. Combined deficiency of Foxo1, Foxo3, and Foxo4 resulted in a severe impairment of SSC self-renewal and a complete block of differentiation, indicating that Foxo3 and Foxo4, although dispensable for male fertility, contribute to SSC function. By conditional inactivation of 3-phosphoinositide–dependent protein kinase 1 (Pdk1) and phosphatase and tensin homolog (Pten) in the male germ line, we found that PI3K signaling regulates Foxo1 stability and subcellular localization, revealing that the Foxos are pivotal effectors of PI3K-Akt signaling in SSCs. We also identified a network of Foxo gene targets — most notably Ret — that rationalized the maintenance of SSCs by the Foxos. These studies demonstrate that Foxo1 expression in the spermatogenic lineage is intimately associated with the stem cell state and revealed what we believe to be novel Foxo-dependent mechanisms underlying SSC self-renewal and differentiation, with implications for common diseases, including male infertility and testicular cancer, due to abnormalities in SSC function.

Authors

Meredith J. Goertz, Zhuoru Wu, Teresa D. Gallardo, F. Kent Hamra, Diego H. Castrillon

×

Figure 6

Regulation of Foxo1 by the PI3K-Akt pathway, Pdk1, and control testes.

Options: View larger image (or click on image) Download as PowerPoint
Regulation of Foxo1 by the PI3K-Akt pathway, Pdk1, and control testes.
 ...
(A) Schematic of the PI3K-Akt-Foxo pathway. A receptor (typically a receptor tyrosine kinase [RTK]) results in PI3K activation and synthesis of 3-phosphoinositides (PIP3). Pten metabolizes PIP3 and acts as a pathway inhibitor. (B) Pdk1 testes were small by P14. Testes from 4-month-old males are shown. Scale bar: 3 mm. (C) GCNA+ cells per tubule and tubules devoid of germ cells per GCNA. *P < 0.0001. (D) Testis histology (H&E) and immunohistochemistry with antibodies as shown. Inset shows alternating Sertoli cells and spermatogonia (asterisks) on basement membrane with complete absence of differentiation and multilayer spermatogenesis. Ki67 demonstrates that spermatogonia are actively proliferating; the Ki67 index in spermatogonia was more than 10% (data not shown). (E) Foxo1 localization in Pdk1 testes at various ages as shown. Pdk1 inactivation promotes the shift of Foxo1 protein from cytoplasm to nucleus at P3. *P < 0.0001. (F) Persistence of SSCs in aged (5-month-old) males. GCNA shows abundant spermatogonia and absence of empty tubules. Plzf and Vasa staining of intact tubules (confocal microscopy) shows the presence of both undifferentiated (Plzf+) and differentiated (Plzf–) Vasa+ spermatogonia in aged Pdk1 testes. Scale bar: 20 μm (D–F).

Copyright © 2023 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts